Description of the time course of the prolactin suppressant effect of the dopamine agonist CQP201-403 by an integrated pharmacokinetic-pharmacodynamic model

British Journal of Clinical Pharmacology
J GrevelJ Rosenthaler

Abstract

Six male volunteers (mean age 24 years) received a single oral dose of 0.025 mg CQP201-403 and placebo in a randomised double-blind crossover design. Fifteen plasma samples were collected over 48 h and were assayed by radioimmunoassay for drug substance and prolactin (PRL). Three of the samples were drawn during sleep on the first study day. The pharmacological effect (E%) of CQP201-403 was expressed as reduction in plasma PRL levels. The pharmacokinetic (PK)-pharmacodynamic (PD) model consisted of two kinetic compartments and an effect compartment linked to the central compartment. A sigmoid Emax model (Hill equation) described the relationship between the drug concentration in the effect compartment and E%. Curve-fitting of PK and PD data provided individual parameter estimates which served to generate computer-simulated PK and PD profiles after single and multiple doses in order to: investigate the in vivo concentration-effect relationship; evaluate the consequence of dosage reduction on the steady-state PD profile; and study the robustness of the response to changes in drug potency and bioavailability.

References

Oct 1, 1978·Physiological Reviews·R I Weiner, W F Ganong
Dec 1, 1979·The Journal of Clinical Investigation·D S CooperF Maloof
Mar 1, 1979·Clinical Pharmacology and Therapeutics·L B SheinerJ Ham
Jan 1, 1985·Clinical Pharmacology and Therapeutics·P Tfelt-Hansen, L Paalzow
Aug 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·P HwangH Friesen
Jun 1, 1984·The Journal of Clinical Endocrinology and Metabolism·G OppizziC Tonon
May 1, 1983·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·J D Grimes, M N Hassan
Aug 1, 1983·The Journal of Clinical Endocrinology and Metabolism·H E CarlsonJ N Wilkins
May 1, 1981·The Journal of Clinical Endocrinology and Metabolism·M E QuigleyS S Yen
Jan 1, 1980·British Journal of Clinical Pharmacology·B WhitingL B Sheiner

❮ Previous
Next ❯

Citations

Jan 1, 1988·European Journal of Clinical Pharmacology·P DominiakD Welzel
May 15, 1988·Experientia·E FlückigerH R Wagner
Jan 1, 1992·European Journal of Clinical Pharmacology·S K GuptaF Holsboer
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·L B Sheiner, J L Steimer
Jan 22, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Don GrootThomas Nakatsui
Mar 1, 1987·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·P F van der HeijdenJ Brownell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.